Erythropoietin improves spatial learning and memory in streptozotocin model of dementia

Pathophysiology

Volumn 20, Issue 2, 2013, Pages 153-158

  Hamidi, Gholamali ^a   Arabpour, Zohreh ^a   Shabrang, Moloud ^b   Rashidi, Bahman ^b   Alaei, Hojjatallah ^b   Sharifi, Mohammad Reza ^b   Salami, Mahmoud ^a   Reisi, Parham ^b,c  

^a KASHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Alzheimer disease; Dementia; Erythropoietin; Intracerebroventricular injections; Learning and Memory; Male rats; Streptozotocin

Indexed keywords

ERYTHROPOIETIN; STREPTOZOCIN;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DEMENTIA; LATENT PERIOD; MALE; MAZE TEST; MEMORY DISORDER; NEUROPROTECTION; NONHUMAN; PASSIVE AVOIDANCE; PRIORITY JOURNAL; RAT; SPATIAL LEARNING; SPATIAL MEMORY;

EID: 84878457138     PISSN: 09284680     EISSN: 1873149X     Source Type: Journal    
DOI: 10.1016/j.pathophys.2013.01.001     Document Type: Article

References (60)

1. Flynn B.L., Ranno A.E. Pharmacologic management of Alzheimer disease, Part II: Antioxidants, antihypertensives, and ergoloid derivatives. Annals of Pharmacotherapy 1999, 33(2):188-197.
2. Bothwell M., Giniger E. Alzheimer's disease: neurodevelopment converges with neurodegeneration. Cell 2000, 102(3):271-273.
3. Smith J.P., Lal V., Bowser D., Cappai R., Masters C.L., Ciccotosto G.D. Stimulus pattern dependence of the Alzheimer's disease amyloid-beta 42 peptide's inhibition of long term potentiation in mouse hippocampal slices. Brain Research 2009, 1269:176-184.
4. Herring A., Ambree O., Tomm M., Habermann H., Sachser N., Paulus W., et al. Environmental enrichment enhances cellular plasticity in transgenic mice with Alzheimer-like pathology. Experimental Neurology 2009, 216(1):184-192.
5. Siren A.L., Knerlich F., Poser W., Gleiter C.H., Bruck W., Ehrenreich H. Erythropoietin and erythropoietin receptor in human ischemic/hypoxic brain. Acta Neuropathologica 2001, 101(3):271-276.
6. Squadrito F., Altavilla D., Squadrito G., Campo G.M., Arlotta M., Quartarone C., et al. Recombinant human erythropoietin inhibits iNOS activity and reverts vascular dysfunction in splanchnic artery occlusion shock. British Journal of Pharmacology 1999, 127(2):482-488.
7. Egrie J.C., Strickland T.W., Lane J., Aoki K., Cohen A.M., Smalling R., et al. Characterization and biological effects of recombinant human erythropoietin. Immunobiology 1986, 172(3-5):213-224.
8. Recny M.A., Scoble H.A., Kim Y. Structural characterization of natural human urinary and recombinant DNA-derived erythropoietin. Identification of des-arginine 166 erythropoietin. Journal of Biological Chemistry 1987, 262(35):17156-17163.
9. Masuda S., Nagao M., Takahata K., Konishi Y., Gallyas F., Tabira T., et al. Functional erythropoietin receptor of the cells with neural characteristics. Comparison with receptor properties of erythroid cells. Journal of Biological Chemistry 1993, 268(15):11208-11216.
10. Masuda S., Okano M., Yamagishi K., Nagao M., Ueda M., Sasaki R. A novel site of erythropoietin production. Oxygen-dependent production in cultured rat astrocytes. Journal of Biological Chemistry 1994, 269(30):19488-19493.
11. El-Kordi A., Radyushkin K., Ehrenreich H. Erythropoietin improves operant conditioning and stability of cognitive performance in mice. BMC Biology 2009, 7:37.
12. Nagai A., Nakagawa E., Choi H.B., Hatori K., Kobayashi S., Kim S.U. Erythropoietin and erythropoietin receptors in human CNS neurons, astrocytes, microglia, and oligodendrocytes grown in culture. Journal of Neuropathology and Experimental Neurology 2001, 60(4):386-392.
13. Ma R., Xiong N., Huang C., Tang Q., Hu B., Xiang J., et al. Erythropoietin protects PC12 cells from beta-amyloid(25-35)-induced apoptosis via PI3K/Akt signaling pathway. Neuropharmacology 2009, 56(6-7):1027-1034.
14. Viviani B., Bartesaghi S., Corsini E., Villa P., Ghezzi P., Garau A., et al. Erythropoietin protects primary hippocampal neurons increasing the expression of brain-derived neurotrophic factor. Journal of Neurochemistry 2005, 93(2):412-421.
15. Nakata S., Matsumura I., Tanaka H., Ezoe S., Satoh Y., Ishikawa J., et al. NF-kappaB family proteins participate in multiple steps of hematopoiesis through elimination of reactive oxygen species. Journal of Biological Chemistry 2004, 279(53):55578-55586.
16. Wu Y., Shang Y., Sun S.G., Liu R.G., Yang W.Q. Protective effect of erythropoietin against 1-methyl-4-phenylpyridinium-induced neurodegeneration in PC12 cells. Neuroscience Bulletin 2007, 23(3):156-164.
17. White L.D., Barone S. Qualitative and quantitative estimates of apoptosis from birth to senescence in the rat brain. Cell Death and Differentiation 2001, 8(4):345-356.
18. Wiese L., Hempel C., Penkowa M., Kirkby N., Kurtzhals J.A. Recombinant human erythropoietin increases survival and reduces neuronal apoptosis in a murine model of cerebral malaria. Malaria Journal 2008, 7:3.
19. Ishrat T., Khan M.B., Hoda M.N., Yousuf S., Ahmad M., Ansari M.A., et al. Coenzyme Q10 modulates cognitive impairment against intracerebroventricular injection of streptozotocin in rats. Behavioural Brain Research 2006, 171(1):9-16.
20. Lannert H., Hoyer S. Intracerebroventricular administration of streptozotocin causes long-term diminutions in learning and memory abilities and in cerebral energy metabolism in adult rats. Behavioral Neuroscience 1998, 112(5):1199-1208.
21. Reisi P., Babri S., Alaei H., Sharifi M.R., Mohaddes G., Noorbakhsh S.M., et al. Treadmill running improves long-term potentiation (LTP) defects in streptozotocin-induced diabetes at dentate gyrus in rats. Pathophysiology 2010, 17(1):33-38.
22. Ghezzi P., Brines M. Erythropoietin as an antiapoptotic, tissue-protective cytokine. Cell Death and Differentiation 2004, 11:37-44.
23. Hengemihle J.M., Abugo O., Rifkind J., Spangler E., Danon D., Ingram D.K. Chronic treatment with human recombinant erythropoietin increases hematocrit and improves water maze performance in mice. Physiology and Behavior 1996, 59(1):153-156.
24. Lu D., Mahmood A., Qu C., Goussev A., Schallert T., Chopp M. Erythropoietin enhances neurogenesis and restores spatial memory in rats after traumatic brain injury. Journal of Neurotrauma 2005, 22(9):1011-1017.
25. Adamcio B., Sargin D., Stradomska A., Medrihan L., Gertler C., Theis F., et al. Erythropoietin enhances hippocampal long-term potentiation and memory. BMC Biology 2008, 6:37.
26. Chu K., Jung K.H., Lee S.T., Kim J.H., Kang K.M., Kim H.K., et al. Erythropoietin reduces epileptogenic processes following status epilepticus. Epilepsia 2008, 49(10):1723-1732.
27. Paxinos G. The Rat Brain in Stereotaxic Coordinates 2005, Academic Press, San Diego. 5th ed. C. Watson (Ed.).
28. Hoveida R., Alaei H., Oryan S., Parivar K., Reisi P. Treadmill running improves spatial memory in an animal model of Alzheimer's disease. Behavioural Brain Research 2011, 216(1):270-274.
29. Reisi P., Alaei H., Babri S., Sharifi M.R., Mohaddes G. Effects of treadmill running on spatial learning and memory in streptozotocin-induced diabetic rats. Neuroscience Letters 2009, 455(2):79-83.
30. Brines M., Cerami A. Emerging biological roles for erythropoietin in the nervous system. Nature Reviews Neuroscience 2005, 6(6):484-494.
31. Brines M.L., Ghezzi P., Keenan S., Agnello D., de Lanerolle N.C., Cerami C., et al. Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proceedings of the National Academy of Sciences of the United States of America 2000, 97(19):10526-10531.
32. Siren A.L., Fratelli M., Brines M., Goemans C., Casagrande S., Lewczuk P., et al. Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress. Proceedings of the National Academy of Sciences of the United States of America 2001, 98(7):4044-4049.
33. Feillet-Coudray C., Rock E., Coudray C., Grzelkowska K., Azais-Braesco V., Dardevet D., et al. Lipid peroxidation and antioxidant status in experimental diabetes. Clinica Chimica Acta 1999, 284(1):31-43.
34. Reagan L.P., Magarinos A.M., Yee D.K., Swzeda L.I., Van B.A., McCall A.L., et al. Oxidative stress and HNE conjugation of GLUT3 are increased in the hippocampus of diabetic rats subjected to stress. Brain Research 2000, 862(1-2):292-300.
35. Zhou Y., Qu Z.Q., Zeng Y.S., Lin Y.K., Li Y., Chung P., et al. Neuroprotective effect of preadministration with Ganoderma lucidum spore on rat hippocampus. Experimental and Toxicologic Pathology 2011, 64(6-8):673-680.
36. Vendramini A.A., de R.W., Labio L.T., Rasmussen N.M., Dos Reis T., Minett P.H., Bertolucci, et al. Interleukin-8-251T>A, interleukin-1alpha-889C>T and Apolipoprotein E polymorphisms in Alzheimer's disease. Genetics and Molecular Biology 2011, 34(1):1-5.
37. Kumar R., Jaggi A.S., Singh N. Effects of erythropoietin on memory deficits and brain oxidative stress in the mouse models of dementia. Korean Journal of Physiology & Pharmacology 2010, 14(5):345-352.
38. Hoyer S. The aging brain. Changes in the neuronal insulin/insulin receptor signal transduction cascade trigger late-onset sporadic Alzheimer disease (SAD). A mini-review. Journal of Neural Transmission 2002, 109(7-8):991-1002.
39. Hoyer S. The brain insulin signal transduction system and sporadic (type II) Alzheimer disease: an update. Journal of Neural Transmission 2002, 109(3):341-360.
40. Siren A.L., Ehrenreich H. Erythropoietin-a novel concept for neuroprotection. European Archives of Psychiatry and Clinical Neuroscience 2001, 251(4):179-184.
41. Kawakami M., Sekiguchi M., Sato K., Kozaki S., Takahashi M. Erythropoietin receptor-mediated inhibition of exocytotic glutamate release confers neuroprotection during chemical ischemia. Journal of Biological Chemistry 2001, 276(42):39469-39475.
42. Genc S., Koroglu T.F., Genc K. Erythropoietin and the nervous system. Brain Research 2004, 1000(1-2):19-31.
43. Signore A.P., Weng Z., Hastings T., Van Laar A.D., Liang Q., Lee Y.J., et al. Erythropoietin protects against 6-hydroxydopamine-induced dopaminergic cell death. Journal of Neurochemistry 2006, 96(2):428-443.
44. Wang Z.Y., Shen L.J., Tu L., Hu D.N., Liu G.Y., Zhou Z.L., et al. Erythropoietin protects retinal pigment epithelial cells from oxidative damage. Free Radical Biology and Medicine 2009, 46(8):1032-1041.
45. Xue Y.Q., Zhao L.R., Guo W.P., Duan W.M. Intrastriatal administration of erythropoietin protects dopaminergic neurons and improves neurobehavioral outcome in a rat model of Parkinson's disease. Neuroscience 2007, 146(3):1245-1258.
46. Ates O., Cayli S., Gurses I., Yucel N., Iraz M., Altinoz E., et al. Effect of pinealectomy and melatonin replacement on morphological and biochemical recovery after traumatic brain injury. International Journal of Developmental Neuroscience 2006, 24(6):357-363.
47. Ozturk E., Demirbilek S., Koroglu A., But A., Begec Z.O., Gulec M., et al. Propofol and erythropoietin antioxidant properties in rat brain injured tissue. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2008, 32(1):81-86.
48. Calapai G., Marciano M.C., Corica F., Allegra A., Parisi A., Frisina N., et al. Erythropoietin protects against brain ischemic injury by inhibition of nitric oxide formation. European Journal of Pharmacology 2000, 401(3):349-356.
49. Chattopadhyay A., Choudhury T.D., Bandyopadhyay D., Datta A.G. Protective effect of erythropoietin on the oxidative damage of erythrocyte membrane by hydroxyl radical. Biochemical Pharmacology 2000, 59(4):419-425.
50. Villa P., Bigini P., Mennini T., Agnello D., Laragione T., Cagnotto A., et al. Erythropoietin selectively attenuates cytokine production and inflammation in cerebral ischemia by targeting neuronal apoptosis. Journal of Experimental Medicine 2003, 198(6):971-975.
51. Zhu L., Wang H.D., Yu X.G., Jin W., Qiao L., Lu T.J., et al. Erythropoietin prevents zinc accumulation and neuronal death after traumatic brain injury in rat hippocampus: in vitro and in vivo studies. Brain Research 2009, 1289:96-105.
52. Yamamoto M., Koshimura K., Kawaguchi M., Sohmiya M., Murakami Y., Kato Y. Stimulating effect of erythropoietin on the release of dopamine and acetylcholine from the rat brain slice. Neuroscience Letters 2000, 292(2):131-133.
53. Tabira T., Konishi Y., Gallyas F. Neurotrophic effect of hematopoietic cytokines on cholinergic and other neurons in vitro. International Journal of Developmental Neuroscience 1995, 13(3-4):241-252.
54. Ehrenreich H., Hinze-Selch D., Stawicki S., Aust C., Knolle-Veentjer S., Wilms S., et al. Improvement of cognitive functions in chronic schizophrenic patients by recombinant human erythropoietin. Molecular Psychiatry 2007, 12(2):206-220.
55. Grasso G., Sfacteria A., Meli F., Fodale V., Buemi M., Iacopino D.G. Neuroprotection by erythropoietin administration after experimental traumatic brain injury. Brain Research 2007, 1182:99-105.
56. Ransome M.I., Turnley A.M. Systemically delivered erythropoietin transiently enhances adult hippocampal neurogenesis. Journal of Neurochemistry 2007, 102(6):1953-1965.
57. Liu X., Xie W., Liu P., Duan M., Jia Z., Li W., et al. Mechanism of the cardioprotection of rhEPO pretreatment on suppressing the inflammatory response in ischemia-reperfusion. Life Sciences 2006, 78(19):2255-2264.
58. Rui T., Feng Q., Lei M., Peng T., Zhang J., Xu M., et al. Erythropoietin prevents the acute myocardial inflammatory response induced by ischemia/reperfusion via induction of AP-1. Cardiovascular Research 2005, 65(3):719-727.
59. Lewczuk P., Hasselblatt M., Kamrowski-Kruck H., Heyer A., Unzicker C., Siren A.L., et al. Survival of hippocampal neurons in culture upon hypoxia: effect of erythropoietin. Neuroreport 2000, 11(16):3485-3488.
60. Morishita E., Masuda S., Nagao M., Yasuda Y., Sasaki R. Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death. Neuroscience 1997, 76(1):105-116.